AEHR
Bearish signalScored 2026-08-16 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Aehr Test Systems
- Nom
- Aehr Test Systems
- Secteur
- Technology
- Industrie
- Semiconductors
- Bourse
- NASDAQ
- Capitalisation
- $1.9B
- Employés
- 138
- PDG
- Gayn Erickson
- Site web
- https://www.aehr.com
- Marché
- COHUFORMTERTRT
Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices. Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types. For more complex integrated circuits like memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices, the FOX-XP and FOX-NP systems facilitate burn-in and functional testing at both the wafer and individual die/module levels. Aehr's FOX-CP system offers a compact, single-wafer solution for verifying the reliability of logic, memory, and photonic devices. A distinguishing offering, the WaferPak Contactor, features an exclusive full-wafer probe card, accommodating wafers up to 300mm, which enables semiconductor manufacturers to conduct comprehensive wafer-level testing and burn-in on Aehr's FOX platforms. Furthermore, the DiePak Carrier provides a reusable, temporary packaging medium, empowering IC manufacturers to complete final testing and burn-in processes for bare die and modules.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 27 417 titres (~3 152 547,16 $ US)
- Insiders
- SLAYEN HOWARD TOLIPHANT LAURA
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$5,786,686
Avg sell (VWAP, 90d window) $121.35 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-14
- Last synced
-
2026-08-21 23:36:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-17 | ROGERS VERNON | Sell · S | 3,994 | $143.77 | $574,217 | Form 4 |
| 2026-08-14 | ROGERS VERNON | Sell · S | 1,000 | $139.00 | $139,000 | Form 4 |
| 2026-08-14 | SLAYEN HOWARD T | Sell · S | 5,700 | $133.03 | $758,264 | Form 4 |
| 2026-08-13 | SALAMONE ALBERTO | Sell · S | 5,472 | $127.50 | $697,688 | Form 4 |
| 2026-08-12 | ENGINEER ADIL | Sell · S | 7,500 | $131.09 | $983,212 | Form 4 |
| 2026-08-12 | OLIPHANT LAURA | Sell · S | 1,717 | $133.00 | $228,361 | Form 4 |
| 2026-08-10 | SPORCK ALISTAIR N | Sell · S | 1,000 | $108.49 | $108,490 | Form 4 |
| 2026-08-04 | SPORCK ALISTAIR N | Sell · S | 1,301 | $101.10 | $131,531 | Form 4 |
| 2026-08-04 | SLAYEN HOWARD T | Sell · S | 20,000 | $108.30 | $2,165,922 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Bearish signalScored 2026-08-16 Drivers: fundamentals. Moteurs : fondamentaux.
Despite solid liquidity (85), AEHR's fundamental trajectory is critically impaired — negative operating margins, a P/S ratio above 56x, and a cash conversion cycle exceeding 500 days signal severe operational and…
The first sentence of the analysis written for AEHR on 2026-08-16 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Unavailable or mixed. Current ratio 10.33 · operating margin -28% — readings disagree
Market snapshot
Financial ratios
| Metric | Trend | 2026-05-29 | 2025-05-30 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 35.3% | 40.6% | 49.1% | 50.4% | 46.6% | |
| Ebit Margin | -23.5% | -7.3% | 18.8% | 22.5% | 18.8% | |
| Ebitda Margin | -23.5% | -1.5% | 20.9% | 23.2% | 19.4% | |
| Operating Profit Margin | -28.3% | -7.3% | 15.2% | 20.6% | 15.3% | |
| Pretax Profit Margin | -23.5% | -7.3% | 18.8% | 22.5% | 18.8% | |
| Continuous Operations Profit Margin | -14.3% | -6.6% | 50.1% | 22.4% | 18.6% | |
| Net Profit Margin | -14.3% | -6.6% | 50.1% | 22.4% | 18.6% | |
| Bottom Line Profit Margin | -14.3% | -6.6% | 50.1% | 22.4% | 18.6% | |
| Current Ratio | 10.330 | 5.677 | 9.312 | 5.459 | 5.448 | |
| Quick Ratio | 8.014 | 2.991 | 5.746 | 3.993 | 4.082 | |
| Solvency Ratio | -0.262 | -0.020 | 2.115 | 0.666 | 0.860 | |
| Cash Ratio | 6.517 | 1.613 | 4.678 | 1.843 | 2.859 | |
| Price To Earnings Ratio | -401.435 | -73.385 | 10.009 | 63.500 | 23.278 | |
| Price To Earnings Growth Ratio | -5.219 | 0.659 | 0.083 | 1.429 | -0.045 | |
| Forward Price To Earnings Growth Ratio | -5.219 | 0.659 | 0.083 | 1.429 | -0.045 | |
| Price To Earnings Diluted Ratio | -401.435 | -73.385 | 10.277 | 66.040 | 24.647 | |
| Price To Earnings Diluted Growth Ratio | -5.219 | 0.658 | 0.083 | 1.403 | -0.050 | |
| Price To Book Ratio | 12.900 | 2.297 | 2.972 | 12.136 | 4.275 | |
| Price To Sales Ratio | 56.632 | 4.786 | 5.009 | 14.123 | 4.289 | |
| Price To Free Cash Flow Ratio | -526.724 | -22.773 | 329.390 | 106.077 | 199.631 | |
| Price To Operating Cash Flow Ratio | -855.489 | -38.136 | 188.892 | 91.645 | 144.561 | |
| Debt To Assets Ratio | 0.040 | 0.073 | 0.048 | 0.064 | 0.016 | |
| Debt To Equity Ratio | 0.045 | 0.088 | 0.056 | 0.083 | 0.020 | |
| Debt To Capital Ratio | 0.043 | 0.081 | 0.053 | 0.077 | 0.019 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.124 | 1.209 | 1.146 | 1.298 | 1.222 | |
| Working Capital Turnover Ratio | 0.417 | 0.735 | 0.827 | 1.067 | 1.720 | |
| Operating Cash Flow Ratio | -0.185 | -0.473 | 0.167 | 0.614 | 0.137 | |
| Operating Cash Flow Sales Ratio | -0.066 | -0.125 | 0.027 | 0.154 | 0.030 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.624 | 1.675 | 0.573 | 0.864 | 0.724 | |
| Debt Service Coverage Ratio | -11.383 | -0.574 | 74.234 | 109.540 | 12.288 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | -5.288 | -8.141 | 3.776 | 73.073 | 1.899 | |
| Operating Cash Flow Coverage Ratio | -0.335 | -0.683 | 0.283 | 1.589 | 1.499 | |
| Capital Expenditure Coverage Ratio | -1.602 | -1.482 | 2.344 | 7.350 | 3.625 | |
| Dividend Paid And Capex Coverage Ratio | -1.602 | -1.482 | 2.344 | 7.350 | 3.625 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -232.208 | -296.571 | 20.891 | 59.316 | 19.041 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 35.3% | ▼-5.3% | ▼-9.1% |
| Ebit Margin | -23.5% | ▼-16.2% | ▼-29.3% |
| Ebitda Margin | -23.5% | ▼-21.9% | ▼-31.2% |
| Operating Profit Margin | -28.3% | ▼-21.0% | ▼-31.4% |
| Pretax Profit Margin | -23.5% | ▼-16.2% | ▼-29.3% |
| Continuous Operations Profit Margin | -14.2% | ▼-7.6% | ▼-28.3% |
| Net Profit Margin | -14.2% | ▼-7.6% | ▼-28.3% |
| Bottom Line Profit Margin | -14.2% | ▼-7.6% | ▼-28.3% |
| Current Ratio | 10.330 | ▲4.653 | ▲3.085 |
| Quick Ratio | 8.014 | ▲5.023 | ▲3.049 |
| Solvency Ratio | -0.262 | ▼-0.242 | ▼-0.934 |
| Cash Ratio | 6.517 | ▲4.904 | ▲3.015 |
| Price To Earnings Ratio | -401.435 | ▼-328.050 | ▼-325.828 |
| Price To Earnings Growth Ratio | -5.219 | ▼-5.878 | ▼-4.600 |
| Forward Price To Earnings Growth Ratio | -5.219 | ▼-5.878 | ▼-4.600 |
| Price To Earnings Diluted Ratio | -401.435 | ▼-328.050 | ▼-326.664 |
| Price To Earnings Diluted Growth Ratio | -5.219 | ▼-5.876 | ▼-4.594 |
| Price To Book Ratio | 12.900 | ▲10.603 | ▲5.984 |
| Price To Sales Ratio | 56.632 | ▲51.846 | ▲39.664 |
| Price To Free Cash Flow Ratio | -526.724 | ▼-503.951 | ▼-543.844 |
| Price To Operating Cash Flow Ratio | -855.489 | ▼-817.354 | ▼-761.784 |
| Debt To Assets Ratio | 0.040 | ▼-0.033 | ▼-0.008 |
| Debt To Equity Ratio | 0.045 | ▼-0.043 | ▼-0.013 |
| Debt To Capital Ratio | 0.043 | ▼-0.038 | ▼-0.011 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.124 | ▼-0.085 | ▼-0.076 |
| Working Capital Turnover Ratio | 0.417 | ▼-0.318 | ▼-0.536 |
| Operating Cash Flow Ratio | -0.185 | ▲0.288 | ▼-0.237 |
| Operating Cash Flow Sales Ratio | -0.066 | ▲0.059 | ▼-0.070 |
| Free Cash Flow Operating Cash Flow Ratio | 1.624 | ▼-0.050 | ▲0.532 |
| Debt Service Coverage Ratio | -11.383 | ▼-10.809 | ▼-48.205 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | -5.287 | ▲2.853 | ▼-18.352 |
| Operating Cash Flow Coverage Ratio | -0.335 | ▲0.348 | ▼-0.806 |
| Capital Expenditure Coverage Ratio | -1.602 | ▼-0.120 | ▼-3.649 |
| Dividend Paid And Capex Coverage Ratio | -1.602 | ▼-0.120 | ▼-3.649 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -232.208 | ▲64.363 | ▼-146.302 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $2.83B | $282.2M | $331.7M | $917.5M | $218.0M | |
| Enterprise value | $2.73B | $267.8M | $288.7M | $893.7M | $187.5M | |
| EV / Sales | 54.50x | 4.54x | 4.36x | 13.76x | 3.69x | |
| EV / Op. cash flow | -823.32x | -36.19x | 164.43x | 89.27x | 124.35x | |
| EV / Free cash flow | -506.92x | -21.61x | 286.73x | 103.33x | 171.72x | |
| EV / EBITDA | -232.21x | -296.57x | 20.89x | 59.32x | 19.04x | |
| Net debt / EBITDA | 9.07x | 15.95x | -3.11x | -1.58x | -3.10x | |
| Current ratio | 10.33x | 5.68x | 9.31x | 5.46x | 5.45x | |
| Income quality | 0.46x | 1.89x | 0.05x | 0.69x | 0.16x | |
| Graham number | — | — | $10 | $6 | $4 | |
| Graham net-net | $4 | $1 | $2 | $2 | $1 | |
| Tax burden | 60.7% | 91.1% | 266.1% | 99.6% | 99.0% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $166.6M | $73.1M | $87.3M | $72.7M | $49.0M | |
| Invested capital | $204.7M | $113.2M | $96.3M | $81.6M | $51.1M | |
| Return on assets | -2.9% | -2.6% | 25.9% | 14.8% | 15.2% | |
| Operating ROA | -7.2% | -3.1% | 8.9% | 16.7% | 18.6% | |
| Return on tangible assets | -3.1% | -3.1% | 25.9% | 14.8% | 15.2% | |
| Return on equity | -3.2% | -3.2% | 29.7% | 19.3% | 18.5% | |
| Return on invested capital | -3.7% | -2.9% | 8.6% | 16.2% | 14.8% | |
| Return on capital employed | -6.2% | -3.2% | 8.6% | 16.3% | 15.2% | |
| Earnings yield | -0.3% | -1.4% | 10.0% | 1.6% | 4.3% | |
| Free cash flow yield | -0.2% | -4.4% | 0.3% | 0.9% | 0.5% | |
| Capex / Op. cash flow | -62.4% | -67.5% | 42.7% | 13.6% | 27.6% | |
| Capex / Depreciation | 73.8% | 147.3% | 55.0% | 302.7% | 135.5% | |
| Capex / Sales | 4.1% | 8.5% | 1.1% | 2.1% | 0.8% | |
| SG&A / Sales | 38.3% | 30.2% | 20.8% | 18.8% | 19.8% | |
| R&D / Sales | 25.3% | 17.7% | 13.2% | 11.0% | 11.4% | |
| Stock comp / Sales | 13.5% | 8.8% | 3.8% | 0.0% | 5.9% | |
| Intangibles / Total assets | 8.2% | 14.5% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 128d | 110d | 55d | 93d | 92d | |
| Days payables outstanding | 76d | 70d | 58d | 104d | 56d | |
| Operating cycle | 594d | 548d | 461d | 364d | 295d | |
| Cash conversion cycle | 518d | 478d | 403d | 260d | 238d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-19 Aehr Test Systems Sinks 10%, Teradyne Falls 5%, FormFactor Drops 6%: What''s Hitting These Semiconductor Test Equipment Stocks? Shares of semiconductor test equipment names are sliding Wednesday morning as a broad derisking wave hits some of 2026''s biggest chip winners.
- 2026-08-19 Can AEHR Turn Silicon Photonics Momentum Into Sustained Growth? Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.
- 2026-08-17 Aehr Test Systems (AEHR) Stock Up 8.6% but GF Value Says Overvalued -- GF Score: 64/100 On August 17, 2026, Aehr Test Systems (AEHR) shares rose 8.6% to a current price of $145.82, reflecting a significant increase in price as it trades near its 52
- 2026-08-17 4 Leveraged ETFs of Last Week Cooling inflation and softer jobs data have eased Fed rate-hike fears, fueling a strong rally in select growth and AI stocks.
- 2026-08-15 Aehr Test Systems $AEHR Shares Sold by Belpointe Asset Management LLC Belpointe Asset Management LLC decreased its holdings in shares of Aehr Test Systems (NASDAQ: AEHR) by 64.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,289 shares of the semiconductor company''s stock after selling 7,892 shares during the quarter.
- 2026-08-14 Aehr Test Systems'' CEO Sells Shares Worth $5.2 Million After a 564% Rally in Price. Here''s a Closer Look at the Transaction. The transaction involved the sale of 40,000 shares at $130.84 per share, totaling ~$5.2 million. All shares were sold from indirect holdings held by a trust, while Gayn''s direct position remained unchanged.
- 2026-08-14 Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year. Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026''s most explosive small caps.
- 2026-08-14 This Aehr Test Systems Analyst Begins Coverage On A Bearish Note; Here Are Top 4 Initiations For Friday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- 2026-08-14 Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More Wall Street flipped the script Friday with a wave of surprise upgrades and downgrades hitting names like Wayfair, Roku, and Fox Corporation, while cooler inflation data reshuffled bets across stocks, bonds, oil, and crypto all at once.
- 2026-08-14 Aehr Test Systems $AEHR Shares Acquired by California State Teachers Retirement System California State Teachers Retirement System grew its stake in Aehr Test Systems (NASDAQ: AEHR) by 2,271.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 41,599 shares of the semiconductor company''s stock after acquiring an additional 39,845 shares during the period. California State Teachers Retirement